PLRX Q1 2024 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$85M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$513,000

Operating Income

-$52M

Net Income

-$47M

EPS (Diluted)

$-0.78

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$32M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$522M

Total Liabilities

$84M

Stockholders' Equity

$437M

Cash & Equivalents

$114M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$1M	-100.0%
Gross Profit	-$513,000	$271,000	-289.3%
Operating Income	-$52M	-$42M	-24.5%
Net Income	-$47M	-$38M	-25.1%